Panel Discussion – Improving the Understanding of IBD Patient Subtype to Permit Bespoke Treatment Options
Time: 9:30 am
day: Conference Day One
Details:
- What procedure can we implement to successfully standardize and identify novel biomarkers that are associated with specific patient subtypes?
- How can we develop companion diagnostics that align with the unique characteristics of each patient subtype to personalize their IBD treatment journey?
- Assessing how patient subtype understanding can permit increased drug response rate
- Exploring the potential for patient subtype-driven drug development to enhance treatment outcomes and reduce adverse effects
